Clinical Trials Browser

Phase 1 × Hematologic Neoplasms × APG-1387 × Clear all

NCT03386526 2023-02-01

APG-1387 in Patients With Advanced Solid Tumors or Hematologic Malignancies

Phase 1 Completed

Other hematologic neoplasm

Hematologic Neoplasms